• Team
• By Location
• By Title
• Advisory Board

Team: Bios

Steven St. Peter, MD, MBA Managing Director

Dr. Steven St. Peter joined MPM Capital in 2004, and he is a Managing Director based in the Boston office. His investment scope includes both venture and buyout transactions across the pharmaceuticals and medical technology industries. He has previous investment experience from Apax Partners and The Carlyle Group. Dr. St. Peter was previously an assistant Clinical Professor of Medicine at Columbia University. He completed his Doctor of Medicine at Washington University and his residency and fellowship at the Hospital of the University of Pennsylvania. Prior to his medical training, he was an investment banker at Merrill Lynch. He also holds an M.B.A. from the Wharton School of the University of Pennsylvania and a B.A. in Chemistry from the University of Kansas. He is on the Board of the New England Venture Capital Association.

Present Boards
EKR Therapeutics, Inc.
MPM Acquisition Corp.
PharmAthene, Inc. (ASE:PIP)
Proteon Therapeutics, Inc.
Rhythm Pharmaceuticals
Syndax Pharmaceuticals, Inc.
Xanodyne Pharmaceuticals, Inc.

Past Boards
Atugen AG
Helicos BioSciences Corp. (NASDAQ:HLCS)
IDEA AG
Omrix Biopharmaceuticals, Inc. (NASDAQ: OMRI)

 

---